Atlas company financials

ZIMMER BIOMET HOLDINGS, INC.

Standardized 19-year financial series for ZIMMER BIOMET HOLDINGS, INC., built from filing-derived source data and exposed in JSON, CSV, and XLSX so it can feed iterFact artifacts or analyst workflows without hand-entering the numbers.

United StatesCIK 0001136869FY2007 → FY2025

Open JSON Download CSV Download XLSX Quarterly JSON Summary JSON Filing index

Latest fiscal year

FY2025

Revenue

$8.2B

Adjusted EBITDA

—

Net result

$705.1M

Net financial debt

$6.9B

Latest source: FY2025 filing · published data snapshot generated April 26, 2026

Phase 2 summary

Latest quarter, TTM, and growth are now pre-computed for chat and templates.

Latest quarter revenue

$2B

TTM revenue

$7.8B

TTM free cash flow

—

Latest quarter net result

$230.9M

Quarterly coverage: 53 periods · latest quarter FY2025-Q3 · TTM revenue growth 4.8%.

What this gives you

A proof-of-concept company data surface, not a dead PDF shelf.

The same standardized payload behind this page is exposed through downloadable CSV and XLSX files plus a stable JSON route. That makes it usable as a live input to iterFact templates, a spreadsheet handoff, or a future API surface without re-normalizing the source documents again.

Source audit

Official links first, raw iterFact payloads right next to them.

Official sources

SEC EDGAR companyfacts
comparative · zimmer-biomet-holdings-inc-fy2007 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2010-02-25 · Retrieved: 2026-04-26T11:44:53.538765+00:00
SEC EDGAR companyfacts
primary · zimmer-biomet-holdings-inc-fy2010 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2011-02-25 · Retrieved: 2026-04-26T11:44:53.538765+00:00
SEC EDGAR companyfacts
us-gaap:ResearchAndDevelopmentExpense · us gaap companyfacts · comparative · zimmer-biomet-holdings-inc-fy2010 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2013-02-27 · Retrieved: 2026-04-26T11:44:53.538765+00:00
SEC EDGAR companyfacts
primary · zimmer-biomet-holdings-inc-fy2011 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2012-02-27 · Retrieved: 2026-04-26T11:44:53.538765+00:00
SEC EDGAR companyfacts
primary · zimmer-biomet-holdings-inc-fy2013 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2014-02-28 · Retrieved: 2026-04-26T11:44:53.538765+00:00

Ten-year series

Headline company financials by fiscal year

Fiscal year	Revenue	Adj. EBITDA	EBIT	Net result	Op. cash flow	Capex	Net debt	Status
FY2007	4B	—	1B	773M	1B	-193M	—	comparative annual fact carried from later 10k · missing accounts receivable · missing adjusted ebitda · missing current assets · missing current liabilities · missing interest expense · missing inventory · missing net financial debt · missing research and development · missing total assets
FY2008	4B	—	1B	849M	1B	-250M	248M	comparative annual fact carried from later 10k · missing adjusted ebitda · missing interest expense · missing research and development
FY2009	4B	—	1B	717M	1B	-105M	436M	missing adjusted ebitda · missing interest expense · missing research and development
FY2010	4B	—	917M	597M	1B	-79M	473M	missing adjusted ebitda · missing interest expense
FY2011	4B	—	1B	761M	1B	-114M	951M	missing adjusted ebitda · missing interest expense
FY2012	4B	—	1B	755M	1B	-115M	937M	missing adjusted ebitda · missing interest expense
FY2013	5B	—	1B	761M	963M	-100M	592M	missing adjusted ebitda · missing interest expense · missing research and development
FY2014	5B	—	1B	720M	1B	-145M	342M	missing adjusted ebitda · missing interest expense · missing research and development
FY2015	6B	—	467M

Filing provenance